News | November 11, 2014

TIDI Products Acquires CFI, Maker of Cath Lab Radiation Protection Equipment

Acquisition enhances radiation protection offerings in the cath lab

November 11, 2014 — TIDI Products LLC has acquired CFI Medical Solutions (CFI) of Fenton, Mich., a diversified medical device manufacturer and engineering resource for hospitals, distributors and global original equipment manufacturers.

CFI has expertise in the design, engineering and manufacturing of radiation protection, infection prevention and patient positioning systems that help clinicians improve the effectiveness of their practices and healthcare systems. The company’s innovation process is collaborative, developing products by working side-by-side with clinicians and physicians.

“We’ve seen some of the value added innovations, such as C-Armor and Zero-Gravity that CFI has developed in partnership with its healthcare professional network” said Kevin McNamara, president and CEO of TIDI. “We look forward to adopting CFI’s culture of innovative thinking throughout our business to further enhance TIDI’s mission of supporting caregivers and preventing infections.”

C-Armor is an expandable and collapsible sterile pouch that adheres to the patient drape at or above the level of the sterile field line during surgical procedures. Zero-Gravity is a suspended radiation protection system that provides greater protection to clinicians during fluoroscopic procedures.

Headquartered in Neenah, Wis., TIDI plans to continue CFI’s engineering and manufacturing operations for its domestic and international customers. CFI employs approximately 300 people at its manufacturing locations in Fenton, Mich., and its Changshu Yushan Protection Products Co. Ltd. facility in Changshu, China.

For more information: www.tidiproducts.com, www.cfimedical.com

Related Content

Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.